Parasitic Diseases clinical trials
The registry lists 55 studies for Parasitic Diseases across more than 10 countries. 8 are recruiting or about to start. 12 of them are mainly about Parasitic Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30. Counting its 33 narrower conditions too, such as Malaria: 2,262 studies, 218 open.
Get an email when these change. Save the Parasitic Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Institute of Allergy and Infectious Diseases (NIAID) (5) · DBL -Institute for Health Research and Development (3) · Drugs for Neglected Diseases (3) · Medicines for Malaria Venture (3) · GlaxoSmithKline (3) · University of California, San Francisco (3) · University of Oxford (3) · Proto Pharma Ltd (2)
What is being tested here
Drugs under test in Parasitic Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Albendazole | 0 | 0 | 6 |
| Mebendazole | 0 | 1 | 3 |
| Emodepside | 0 | 0 | 2 |
| Permethrin | 0 | 1 | 2 |
| Praziquantel | 0 | 0 | 2 |
| Ivermectin | 0 | 0 | 2 |
| Pyronaridine | 0 | 0 | 1 |
| Benzonidazole | 0 | 0 | 1 |
| Nifurtimox | 0 | 0 | 1 |
| Artenimol | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 3, phase 3 first
- May 2027FocaL Mass Drug Administration for Vivax Malaria Elimination · Phase 3 · University of California, San Francisco
- Mar 2027Microbiome and Malnutrition in Pregnancy · The Hospital for Sick Children
- Apr 2027A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months · GlaxoSmithKline
Who these studies take
Of the 6 Parasitic Diseases studies recruiting now, 2 (33%) set no upper age limit and 2 (33%) stop at 75 or younger. 4 (67%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 3 (50%) | 3 (50%) |
| 18 | 5 (83%) | 5 (83%) |
| 30 | 5 (83%) | 5 (83%) |
| 40 | 5 (83%) | 5 (83%) |
| 50 | 5 (83%) | 5 (83%) |
| 65 | 5 (83%) | 5 (83%) |
| 75 | 4 (67%) | 4 (67%) |
| 85 | 4 (67%) | 4 (67%) |
Across all 55 studies, recruiting or not: 55% stop at 75 or younger and 51% at 65; 58% take children; 5% are for women only and 4% for men only; 44% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 50 of 55. Browse all 55 → or search them.
- Diagnosis and Treatment of Leishmania InfectionsRecruitingNCT003441881 country
- The Parasite and Infestation StudyRecruitingNCT078499071 country
- Activation and Function of Eosinophils in Conditions With Blood or Tissue EosinophiliaRecruitingNCT000014061 country
- FocaL Mass Drug Administration for Vivax Malaria EliminationRecruitingNCT05690841Phase 31 country
- Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised OutpatientsRecruitingNCT07110636Not applicable1 country
- Activity of Mouthwashes Againgst Entamoeba Spp.Not yet recruitingNCT07210814Not applicable1 country
- A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 MonthsRecruitingNCT07036159Phase 21 country
- The Impact of Parasitic Infection on Multiple Sclerosis and Nephrotic SyndromeNot yet recruitingNCT06256471
- Host Response to Infection and Treatment in Filarial DiseasesActive, not recruitingNCT000012301 country
- A Study to Assess the Safety and Effectiveness of Two Experimental Malaria VaccinesCompletedNCT05978037Phase 1/21 country
- Microbiome and Malnutrition in PregnancyActive, not recruitingNCT049921041 country
- Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. FalciparumCompletedNCT05979207Phase 11 country
- Development and Validation of (Bio)Sensors for the Identification of PathogensCompletedNCT065488411 country
- Safety, Tolerability and PK of Single and Multiple Doses of Oxantel Pamoate TabletsCompletedNCT06606860Phase 11 country
- HIV And Parasitic Infection (HAPI) StudyCompletedNCT05323396Not applicable1 country
- Pyronaridine in Healthy Adult Participants Infected With Blood Stage MalariaCompletedNCT05287893Phase 11 country
- A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice InfestationCompletedNCT05565820Phase 41 country
- A Study to Compare Two Dosing Regimens for a New Malaria VaccineActive, not recruitingNCT06141057Phase 11 country
- New Therapies and Biomarkers for Chagas InfectionCompletedNCT03981523Phase 21 country
- Microbiome and Malnutrition in Pregnancy (MMiP)Active, not recruitingNCT051086751 country
- Egg Intervention During Pregnancy in IndonesiaActive, not recruitingNCT04694235Not applicable1 country
- Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination ActivitiesCompletedNCT04864444Not applicable1 country
- Sulfur vs. Different Regimes of Permethrin for ScabiesCompletedNCT06396507Phase 31 country
- Emodepside Phase II Trial for Treatment of OnchocerciasisActive, not recruitingNCT05180461Phase 22 countries
- A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of ScabiesCompletedNCT02094716Phase 24 countries
- PK, Safety and Tolerability of Single and Multiple Doses of Oxfendazole TabletsCompletedNCT04920292Phase 11 country
- Infections in Migrants in Sweden - the Importance of Malaria and Other Parasitic InfectionsStatus unknownNCT050868871 country
- Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) SporozoitesCompletedNCT04310085Phase 11 country
- Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory CohortCompletedNCT02910037Not applicable1 country
- Compassionate Use of Triclabendazole for the Treatment of Parasites (Prior to FDA Approval; Expanded Access Program)No longer availableNCT01931085
- Malaria Elimination Pilot Study in Military Forces in CambodiaStatus unknownNCT02653898Phase 41 country
- Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian InfantsCompletedNCT00289185Phase 21 country
- Enterobius Vermicularis Infestation of the AppendixCompletedNCT045762731 country
- First in Man Clinical Trial of Emodepside (BAY 44-4400)CompletedNCT02661178Phase 11 country
- Frequency of Parasite Infestation in Patients With Chronic Spontaneous UrticariaCompletedNCT043149991 country
- IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating CentresCompletedNCT026891933 countries
- Parasitic Infections of the Gastrointestinal TractTerminatedNCT000011621 country
- The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon IslandsCompletedNCT01080989Not applicable1 country
- Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese ChildrenCompletedNCT00307021Phase 21 country
- School-based Programme of Malaria Diagnosis and Treatment in Southern MalawiCompletedNCT02213211Not applicable1 country
- Inoculating Celiac Disease Patients With the Human Hookworm Necator Americanus: Evaluating Immunity and Gluten-sensitivityCompletedNCT00671138Phase 21 country
- Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158CompletedNCT01533961Phase 11 country
- Randomized Study of Albendazole in Patients With Epilepsy Due to NeurocysticercosisCompletedNCT00004403Not applicable
- Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in KenyaCompletedNCT01425073Not applicable1 country
- A Safety Study of Mebendazole in Children 2 to 10 Years of AgeCompletedNCT01173562Phase 31 country
- Superiority of ArTiMist Versus Quinine in Children With Severe MalariaCompletedNCT01258049Phase 33 countries
- Alternate Chemotherapy Regimens for the Clearance of W.Bancrofti InfectionCompletedNCT02005653Phase 41 country
- Optimisation of Controlled Human Malaria Infection Using Sporozoites Administered by Needle and SyringeCompletedNCT01465048Not applicable1 country
- Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis EliminationCompletedNCT01586169Not applicable1 country
- Efficacy of ArTiMist™ in ChildrenCompletedNCT01047436Phase 2